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Primary cultures of human umbilical vein endothelial cells were inoculated with
plaque-purified Rickettsia rickettsii. After adsorption of rickettsiae, monolayers
were overlaid with medium containing 0.5% agarose. Small plaques appeared on
day 4 postinoculation, and distinct 1- to 2-mm plaques were observed on day 5.
Plaquing efficiency was less than that of primary chicken embryo cells in the same
medium. Human endothelial cell monolayers were susceptible to infection by R.
rickettsii and underwent necrosis as demonstrated by supravital staining. The
topographic association of endothelial cell necrosis and rickettsial infection in the
plaque model confirmed the direct cytopathic effect of R. rickettsii on human
endothelium. Uninfected cells appeared normal by supravital staining and trans-
mission electron microscopy. This model offers the possibility of investigating
rickettsial pathogenesis and mechanisms of enhanced severity of Rocky Mountain
spotted fever in specific genetically determined conditions.
Experimental evidence indicates that host-
mediated pathogenic mechanisms, such as im-
munopathology (2, 3, 10, 11, 18), Shwartzman
phenomenon-like blood coagulation (2, 3, 10, 11,
21), and inflammation, are not the primary
mechanisms of injury in infection by Rickettsia
rickettsii. Localized effects of kallikrein are
probably events secondary to the primary patho-
genic mechanism(s) (25). Occlusive vascular
thrombosis is infrequent, occurs only in areas of
localized rickettsial infection, and has not been
demonstrated as a primary pathogenic mecha-
nism (1, 16, 21).
In contrast, the direct cytopathic effect of R.
rickettsii has been suggested by the topographic
association of vascular injury with focal rickett-
sial infection (1, 15, 16, 21) and has also been
documented in primary chicken embryo cell
monolayers (14). Plaques representing necrosis
of host chicken cells were the sites of centrifugal
spread of rickettsial infection from the point of
inoculation of an infectious unit. The direct
cytopathic effect was confirmed by ultrastruc-
tural documentation of a statistically significant
relationship between cytopathology and quanti-
ty of rickettsiae within the cell. This study
extends the plaque model to the target cell most
relevant to Rocky Mountain spotted fever, the
human endothelial cell.
MATERIALS AND METHODS
Rickettsia. A lyophilized ampoule of plaque-purified
R. rickettsii (Sheila Smith strain, generously provided
by C. L. Wisseman, Jr.) was reconstituted and pas-
saged in yolk sacs of 5-day-old specific-pathogen-free
embryonated hens' eggs for production of rickettsial
stock (12). Infected pooled yolk sacs were frozen in
samples at -70°C. R. rickettsii stock was titrated by
plaque assay in primary chicken embryo cells and was
found to contain 1.89 x 106 PFU per ml with no
bacterial or fungal contamination.
Primary cultures of human vascular endothelial cells.
The veins of fresh unmarred umbilical cords were
cannulated, rinsed with phosphate-buffered saline
(PBS), filled with 0.1% collagenase in PBS, and incu-
bated at 37°C for 20 min (4). Cells were flushed from
the vein, recovered by centrifugation, and then sus-
pended in RPMI 1640 culture medium supplemented
with 15% heat-inactivated fetal bovine serum, 100 IU
of penicillin per ml, and 100 ,ug of streptomycin per ml.
Cells from a single cord were seeded onto less than 50
cm2 of tissue culture plastic ware with or without glass
cover slips, and were maintained at 37°C in a humid
atmosphere containing 5% CO2. The medium was
changed every second or third day. Cultures which
approached confluency within a week were rinsed
carefully in medium 199 and maintained at least 24 h in
this antibiotic-free medium containing 15% fetal bo-
vine serum before inoculation with R. rickettsii.
Plaque assay. The rickettsial plaque techniques of
Wike and Burgdorfer (22) and Wike et al. (23, 24) were
followed. Samples of R. rickettsii stock were thawed
quickly at 37°C and diluted 1/3,000 in 3.7% chilled
brain heart infusion broth (Difco Laboratories). Cul-
ture medium was removed from cells, and 0.1 ml of
diluted rickettsiae was inoculated onto human umbili-
cal vein endothelial cell monolayers. Assays of infec-
tivity as plaque-forming units were also performed in
parallel on this inoculum in both primary chicken
embryo cells and Vero cells. After 30 min for adsorp-
tion and penetration to occur, medium 199 with 0.5%
301
302 WALKER, FIRTH, AND EDGELL
agarose and 15% fetal bovine serum was added. Infect-
ed monolayers were incubated at 37°C in a 5% CO2
atmosphere. On day 4 postinoculation 1.5 ml of a
second overlay containing 0.1% neutral red was add-
ed, and cells were incubated for another 24 h, after
which monolayers were observed for quantity of
plaques and were prepared for immunofluorescent and
transmission electron microscopic examination.
Immunofluorescence for R. rickettsii. Agarose gel
overlays were separated from the sides of the petri
dishes containing cover slips and were gently peeled
off the dish. Monolayers on glass cover slips were
washed three times in sterile PBS and were fixed in
100% acetone for 5 s. Direct immunofluorescent stain-
ing for R. rickettsii was performed with a specific
rabbit anti-R. rickettsii globulin fraction fluorescein
isothiocyanate conjugate (Viral and Rickettsial Prod-
ucts Branch, Biologic Products Division, Centers for
Disease Control). Immunofluorescent technique and
conjugate specificity criteria have been previously
published (7, 16, 17). The monolayers were incubated
with a 1:160 dilution of the conjugate for 30 min,
followed by a 30-min wash in PBS, and a rinse in
distilled water. Cover slips were mounted on micro-
scope slides with 90% glycerol-10% PBS, pH 9. A
Leitz Ortholux UV microscope, utilizing incident
beam illumination with barrier and exciter filters for
fluorescein isothiocyanate fluorescence microscopy,
was employed for examination of the monolayers.
Immunofluorescence of VIIIR:Ag. Factor VIII-relat-
ed antigen (VIIIR:Ag), a specific marker for vascular
endothelial cells (8), was demonstrated by indirect
immunofluorescence in cells grown on glass cover
slips and fixed in acetone. The primary antiserum was
from a rabbit immunized with an agarose void volume
of a commercial human plasma factor VIII concen-
trate. To produce a monospecific reagent, the antise-
rum was absorbed with a 3 to 30% ethanol precipitate
of human plasma. The specificity of this antiserum for
VIIIR:Ag was demonstrated by a single precipitation
line in immunodiffusion with normal human plasma
and no precipitation with homozygous von Willebrand
disease plasma (9). The secondary antiserum, supplied
by Litton Bionetics, was rhodamine-conjugated goat
antibody to rabbit immunoglobulins. UV microscopy
utilized barrier and exciter filters for rhodamine fluo-
rescence.
Electron microscopy. After removal of agarose over-
lays, endothelial cell monolayers were fixed with 2.5%
glutaraldehyde in Sorensen buffer or 0.1 M cacodylate
buffer for 30 min (6), washed twice in either Sorensen
buffer or cacodylate buffer with 7% sucrose, and
postfixed with 1% osmium tetroxide for 30 min. The
monolayers were dehydrated through a graded series
of ethanol and hydroxypropyl methacrylate solutions
and embedded in Poly/Bed 812 (Polysciences). After
overnight polymerization at 37°C and 24 h at 60°C, the
embedded monolayers were separated from the plastic
petri dishes. Rickettsial plaques could be discerned
within the embedded monolayer as clear zones about 1
to 2 mm in diameter with a stereomicroscope. Plaques
with adjacent cells were cut out and re-embedded in
flat iiiolds with Poly/Bed 812. The monolayer was
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Ultrathin sectioning was performed on a Sorvall MT-
2B ultramicrotome using an MJO diamond knife. Ura-
nyl acetate and lead citrate were used for staining of
the sections (13), and these were examined on either a
Zeiss 10A or JEOL 100B transmission electron micro-
scope.
RESULTS
Plaques appeared in R. rickettsii-inoculated
monolayers of human vascular endothelial cells
from each of the donor sources. Plaques were
first observed on day 4 after inoculation and
developed into distinct clear zones 1 to 2 mm in
diameter by day 5 (Fig. 1). The plaques were
confirmed to be the localized sites of R. rickettsii
infection by immunofluorescence (Fig. 2) and
electron microscopy (Fig. 3 and 4). The mono-
layers were documented to be of endothelial
origin by the presence of cytoplasmic immuno-
fluorescent VIIIR:Ag (Fig. 5) and characteristic
Weibel-Palade bodies (Fig. 6). The relative sus-
ceptibility of endothelial cell monolayers from
different individual donors is shown in Table 1.
Human endothelial monolayers supported
plaque formation less efficiently than did pri-
mary chicken embryo cells and Vero cells. How-
ever, the endothelial monolayers exhibited rela-
tively consistent plaque counts. Over the
observed range of 67 to 80% confluency of
endothelial monolayers, there was no difference
in plaquing efficiency. In the small sample exam-
ined, there were no consistent differences in
susceptibility to plaque formation correlating
with the sex of the donor.
Phase-contrast microscopy revealed that the
plaques consisted of a zone of granular, necrotic
cells surrounded by viable cells containing cyto-
plasmic neutral red (Fig. 1). UV microscopy
demonstrated that endothelial cells within the
plaques were rounded and opaque and contained
a large amount of rickettsial antigen. Endothelial
cells at the margin of the plaque contained many
distinct bacillary forms of R. rickettsii, and most
marginal cells exhibited the normal polygonal
configuration of uninfected endothelial cells dis-
tant from the plaque. A decreasing quantity of
rickettsiae per cell was observed with greater
concentric distance from the margin of the
plaque. Electron microscopy demonstrated the
typical ultrastructural appearance of R.
rickettsii in direct contact with the cytosol of
endothelial cells (Fig. 3 and 4). The organisms
were observed in longitudinal and cross sections
as either round or bacillary with an outer
gram-negative-type cell wall, an inner plasma
membrane, and cytosol containing numerous
FIG. 2. Numerous immunofluorescent R. rickettsii predominantly within the cytoplasm of human endothelial
cells near the margin of a plaque. FITC-anti-R. rickettsii globulin. x800. The bar represents 10 ,um.
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FIG. 3. Electron photomicrograph of a human endothelial cell near the margin of a plaque demonstrates 10 R.
rickettsii (arrows) within the cytosol. Uranyl acetate-lead citrate. x12,000. The bar represents 1 p.m.
ribosomes and few electron-dense strands. Oc-
casional organisms were observed with the ap-
pearance of a stage of binary fission.
DISCUSSION
This study establishes a plaque model for






FIG. 4. Electron photomicrograph of an elongated
form of R. rickettsii surrounded by an electron-lucent
zone that is in direct contact with the cytosol of a
human endothelial cell. Uranyl acetate-lead citrate.
x36,000. The bar represents 0.2 p.m.
rickettsii. The demonstration that human endo-
thelial cell monolayers are susceptible to infec-
tion by R. rickettsii and that infected endothelial
cells undergo necrosis will allow examination in
vitro of questions relating to the pathogenesis of
Rocky Mountain spotted fever and to the rick-
ettsia-endothelial cell interaction. Plaque forma-
tion in human endothelial cells confirms that
complex host-mediated pathogenic mechanisms,
such as immunopathology, inflammation, and
coagulation, are not required for host cell injury
and necrosis in rickettsial infection. Moreover,
the topographic association of endothelial cell
necrosis and rickettsial infection in the plaque
model confirms the direct cytopathic effect of R.
rickettsii on human endothelium. Likewise, the
absence of cytopathic effect in uninfected cells
adjacent to the focus of rickettsial infection
argues strongly against the hypothesis of a po-
tent extracellular toxin of R. rickettsii.
The reduced plaquing efficiency of R. rickett-
sii in human endothelium when compared with
primary chicken embryo cells and Vero cells
suggests that human infection with R. rickettsii
is truly accidental and does not support the
hypothesis that there is a specific rickettsial
tropism determined by a unique endothelial cell
receptor and a rickettsial attachment protein.
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nature. It is possible, however, that differences
in plaquing efficiency may have been affected by
FIG. 6. Electron photomicrograph of a Weibel-Pa-
lade body in the cytoplasm of a human endothelial cell
in a monolayer infected with R. ric kettsii. Uranyl
acetate-lead citrate. x80,000. The bar represents 0.1
,um.
exposure of cells to different media constituents
during growth of the monolayers. For example,
endothelial cell monolayers did not develop
plaques when maintained in antibiotic-free
RPMI 1640 after inoculation with rickettsiae.
Rickettsial plaque formation in cultured hu-
man endothelial cells is a model of Rocky Moun-
tain spotted fever which offers the unique possi-
bility of investigating the interaction of
rickettsiae and individual hosts of different ge-
netic backgrounds. It makes possible the exami-
nation of hypothetical mechanisms for the high-
er fatality-to-case ratios observed in males
(8.2%) compared with females (4.5%), in non-
whites (13.9%) compared with whites (5.8%) (5),
and in individuals with G6PD A- compared with
G6PD B (19, 20). These in vitro experiments
with human cells offer the advantages of human
origin, defined dose of inoculum and duration of
infection, and absence of other medical compli-
cations over animal models and naturally occur-
ring human disease.
TABLE 1. Effect of donor sex and monolayer confluency on the quantity and onset of plaques in endothelial
cells inoculated with R. rickettsii
Culturea No. of plaquesb % Confluency Donor Day of Daysex appearance distinct
HUV 1 1.8 x 105 80 M 4 5
HUV 2 1.2 x 105 80 F 4 5
HUV 3 7.8 x 104 80 F 4 5
HUV 4 1.2 x 105 67 M NE' 5
HUV 5 2.1 x 105 75 M NE 5
HUV 6 1.8 x 105 75 F NE 5
CEC 1.9 x 106 100 -d
Vero 5.7 x 105 100
a HUV, Human umbilical vein; CEC, chicken embryo culture.
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